Literature DB >> 12969961

Integration of apoptosis and telomere erosion in virus-specific CD8+ T cells from blood and tonsils during primary infection.

Maria Vieira D Soares1, Fiona J Plunkett, Caroline S Verbeke, Joanne E Cook, Jeff M Faint, Lavina L Belaramani, Jean M Fletcher, Nicholas Hammerschmitt, Malcolm Rustin, Wolfgang Bergler, Peter C L Beverley, Mike Salmon, Arne N Akbar.   

Abstract

Human-virus-specific CD8+ T cells that are found during primary infection have been studied almost exclusively in the peripheral blood, and it is unclear whether these cells are regulated in the same way as those in secondary lymphoid tissue. We investigated, therefore, the control of apoptosis and telomere erosion of Epstein-Barr virus (EBV)-specific CD8+ T cells found in the blood and tonsils of the same patients during acute infectious mononucleosis (AIM). Although the clonal composition of CD8+ T cells as determined by heteroduplex analysis was similar in both compartments, there was greater CD28 expression in the tonsil population, indicating that they were less differentiated. EBV-specific CD8+ T cells in both tissue types were extremely susceptible to apoptosis related to low Bcl-2 expression and were dependent on exogenous cytokines such as interleukin-2 (IL-2), IL-15, and interferon-alpha/beta (IFN-alpha/beta) for survival. In both compartments, however, these cells maintained their telomere lengths through telomerase induction. Thus, apoptosis-prone EBV-specific CD8+ T cells found during acute infection have to be rescued from death to persist as a memory population. However, signals that induce telomerase ensure that the rescued cells retain their replicative capacity. Significantly, these processes operate identically in cells found in blood and secondary lymphoid tissue.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12969961     DOI: 10.1182/blood-2003-06-1791

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  7 in total

Review 1.  Expression and regulation of telomerase in human T cell differentiation, activation, aging and diseases.

Authors:  Michael Patrick; Nan-Ping Weng
Journal:  Cell Immunol       Date:  2019-09-19       Impact factor: 4.868

2.  Persistence of tumor infiltrating lymphocytes in adoptive immunotherapy correlates with telomere length.

Authors:  Xinglei Shen; Juhua Zhou; Karen S Hathcock; Paul Robbins; Daniel J Powell; Steven A Rosenberg; Richard J Hodes
Journal:  J Immunother       Date:  2007-01       Impact factor: 4.456

3.  CD4+ T-lymphocyte telomere length is related to fibrosis stage, clinical outcome and treatment response in chronic hepatitis C virus infection.

Authors:  Matthew Hoare; William T H Gelson; Abhi Das; Jean M Fletcher; Susan E Davies; Martin D Curran; Sarah L Vowler; Mala K Maini; Arne N Akbar; Graeme J M Alexander
Journal:  J Hepatol       Date:  2010-04-22       Impact factor: 25.083

4.  Telomerase insufficiency in rheumatoid arthritis.

Authors:  Hiroshi Fujii; Lan Shao; Inés Colmegna; Jörg J Goronzy; Cornelia M Weyand
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-02       Impact factor: 11.205

5.  Tonsillar homing of Epstein-Barr virus-specific CD8+ T cells and the virus-host balance.

Authors:  Andrew D Hislop; Michael Kuo; Adrian B Drake-Lee; Arne N Akbar; Wolfgang Bergler; Nicolas Hammerschmitt; Naeem Khan; Umaimainthan Palendira; Alison M Leese; Judith M Timms; Andrew I Bell; Christopher D Buckley; Alan B Rickinson
Journal:  J Clin Invest       Date:  2005-08-18       Impact factor: 14.808

6.  Telomere erosion in memory T cells induced by telomerase inhibition at the site of antigenic challenge in vivo.

Authors:  John R Reed; Milica Vukmanovic-Stejic; Jean M Fletcher; Maria Vieira D Soares; Joanne E Cook; Catherine H Orteu; Sarah E Jackson; Katie E Birch; Graham R Foster; Mike Salmon; Peter C L Beverley; Malcolm H A Rustin; Arne N Akbar
Journal:  J Exp Med       Date:  2004-05-17       Impact factor: 14.307

Review 7.  The T-cell Response to Epstein-Barr Virus-New Tricks From an Old Dog.

Authors:  Heather M Long; Benjamin J Meckiff; Graham S Taylor
Journal:  Front Immunol       Date:  2019-09-18       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.